Pramlintide: an agent for glycemic control plus weight control?
Riddle
Matthew C
MC
Department of Medicine, Oregon Health & Science University, Portland 97201, USA. riddlem@ohsu.edu
D000682:Amyloid / Q000009:adverse effects / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D058228:Islet Amyloid Polypeptide; D015203:Reproducibility of Results
D000682:Amyloid; D001786:Blood Glucose; D058228:Islet Amyloid Polypeptide; C105254:pramlintide